nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCD—Azacitidine—Gemcitabine—pancreatic cancer	0.0154	1	CbGdCrCtD
Ingenol Mebutate—Application site burn—Fluorouracil—pancreatic cancer	0.0133	0.1	CcSEcCtD
Ingenol Mebutate—Periorbital oedema—Sunitinib—pancreatic cancer	0.00896	0.0673	CcSEcCtD
Ingenol Mebutate—Scab—Fluorouracil—pancreatic cancer	0.00878	0.066	CcSEcCtD
Ingenol Mebutate—Eyelid oedema—Sunitinib—pancreatic cancer	0.00702	0.0527	CcSEcCtD
Ingenol Mebutate—Application site pain—Fluorouracil—pancreatic cancer	0.00635	0.0477	CcSEcCtD
Ingenol Mebutate—Swelling—Tamoxifen—pancreatic cancer	0.0034	0.0256	CcSEcCtD
Ingenol Mebutate—Ulcer—Irinotecan—pancreatic cancer	0.00308	0.0232	CcSEcCtD
Ingenol Mebutate—Ulcer—Gemcitabine—pancreatic cancer	0.003	0.0226	CcSEcCtD
Ingenol Mebutate—Ulcer—Fluorouracil—pancreatic cancer	0.00295	0.0222	CcSEcCtD
Ingenol Mebutate—Swelling—Fluorouracil—pancreatic cancer	0.0023	0.0173	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Sunitinib—pancreatic cancer	0.0023	0.0173	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Erlotinib—pancreatic cancer	0.00229	0.0172	CcSEcCtD
Ingenol Mebutate—Infestation—Erlotinib—pancreatic cancer	0.00229	0.0172	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Erlotinib—pancreatic cancer	0.00222	0.0167	CcSEcCtD
Ingenol Mebutate—Infestation—Sunitinib—pancreatic cancer	0.00198	0.0149	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Sunitinib—pancreatic cancer	0.00198	0.0149	CcSEcCtD
Ingenol Mebutate—Eye disorder—Erlotinib—pancreatic cancer	0.00192	0.0144	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Fluorouracil—pancreatic cancer	0.00181	0.0136	CcSEcCtD
Ingenol Mebutate—Erythema—Tamoxifen—pancreatic cancer	0.00181	0.0136	CcSEcCtD
Ingenol Mebutate—Erythema—Erlotinib—pancreatic cancer	0.00179	0.0134	CcSEcCtD
Ingenol Mebutate—Eye disorder—Sunitinib—pancreatic cancer	0.00166	0.0125	CcSEcCtD
Ingenol Mebutate—Swelling—Docetaxel—pancreatic cancer	0.00166	0.0125	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Fluorouracil—pancreatic cancer	0.00156	0.0117	CcSEcCtD
Ingenol Mebutate—Infestation—Fluorouracil—pancreatic cancer	0.00156	0.0117	CcSEcCtD
Ingenol Mebutate—Erythema—Sunitinib—pancreatic cancer	0.00155	0.0116	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Fluorouracil—pancreatic cancer	0.00152	0.0114	CcSEcCtD
Ingenol Mebutate—Infection—Tamoxifen—pancreatic cancer	0.00147	0.011	CcSEcCtD
Ingenol Mebutate—Infection—Erlotinib—pancreatic cancer	0.00145	0.0109	CcSEcCtD
Ingenol Mebutate—Ulcer—Epirubicin—pancreatic cancer	0.00144	0.0108	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Erlotinib—pancreatic cancer	0.00143	0.0108	CcSEcCtD
Ingenol Mebutate—Ulcer—Doxorubicin—pancreatic cancer	0.00133	0.01	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Docetaxel—pancreatic cancer	0.00131	0.00984	CcSEcCtD
Ingenol Mebutate—Infection—Sunitinib—pancreatic cancer	0.00125	0.00943	CcSEcCtD
Ingenol Mebutate—Erythema—Gemcitabine—pancreatic cancer	0.00124	0.00934	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Sunitinib—pancreatic cancer	0.00124	0.00931	CcSEcCtD
Ingenol Mebutate—Erythema—Fluorouracil—pancreatic cancer	0.00122	0.00918	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Docetaxel—pancreatic cancer	0.00113	0.00848	CcSEcCtD
Ingenol Mebutate—Infestation—Docetaxel—pancreatic cancer	0.00113	0.00848	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Docetaxel—pancreatic cancer	0.0011	0.00824	CcSEcCtD
Ingenol Mebutate—Eye pain—Epirubicin—pancreatic cancer	0.00109	0.00822	CcSEcCtD
Ingenol Mebutate—Infection—Irinotecan—pancreatic cancer	0.00103	0.00777	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Irinotecan—pancreatic cancer	0.00102	0.00767	CcSEcCtD
Ingenol Mebutate—Eye pain—Doxorubicin—pancreatic cancer	0.00101	0.00761	CcSEcCtD
Ingenol Mebutate—Infection—Gemcitabine—pancreatic cancer	0.00101	0.00757	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000994	0.00747	CcSEcCtD
Ingenol Mebutate—Infection—Fluorouracil—pancreatic cancer	0.00099	0.00744	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000977	0.00735	CcSEcCtD
Ingenol Mebutate—Eye disorder—Docetaxel—pancreatic cancer	0.000946	0.00711	CcSEcCtD
Ingenol Mebutate—Headache—Tamoxifen—pancreatic cancer	0.000924	0.00695	CcSEcCtD
Ingenol Mebutate—Headache—Erlotinib—pancreatic cancer	0.000914	0.00687	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000883	0.00664	CcSEcCtD
Ingenol Mebutate—Erythema—Docetaxel—pancreatic cancer	0.000881	0.00663	CcSEcCtD
Ingenol Mebutate—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000817	0.00614	CcSEcCtD
Ingenol Mebutate—Headache—Sunitinib—pancreatic cancer	0.000791	0.00595	CcSEcCtD
Ingenol Mebutate—Infestation—Epirubicin—pancreatic cancer	0.000761	0.00572	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Epirubicin—pancreatic cancer	0.000761	0.00572	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Epirubicin—pancreatic cancer	0.000739	0.00556	CcSEcCtD
Ingenol Mebutate—Infection—Docetaxel—pancreatic cancer	0.000715	0.00537	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Docetaxel—pancreatic cancer	0.000705	0.0053	CcSEcCtD
Ingenol Mebutate—Infestation NOS—Doxorubicin—pancreatic cancer	0.000704	0.00529	CcSEcCtD
Ingenol Mebutate—Infestation—Doxorubicin—pancreatic cancer	0.000704	0.00529	CcSEcCtD
Ingenol Mebutate—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000684	0.00514	CcSEcCtD
Ingenol Mebutate—Headache—Irinotecan—pancreatic cancer	0.000652	0.0049	CcSEcCtD
Ingenol Mebutate—Eye disorder—Epirubicin—pancreatic cancer	0.000638	0.0048	CcSEcCtD
Ingenol Mebutate—Headache—Gemcitabine—pancreatic cancer	0.000635	0.00477	CcSEcCtD
Ingenol Mebutate—Headache—Fluorouracil—pancreatic cancer	0.000624	0.00469	CcSEcCtD
Ingenol Mebutate—Erythema—Epirubicin—pancreatic cancer	0.000594	0.00447	CcSEcCtD
Ingenol Mebutate—Eye disorder—Doxorubicin—pancreatic cancer	0.00059	0.00444	CcSEcCtD
Ingenol Mebutate—Erythema—Doxorubicin—pancreatic cancer	0.00055	0.00414	CcSEcCtD
Ingenol Mebutate—Infection—Epirubicin—pancreatic cancer	0.000482	0.00362	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Epirubicin—pancreatic cancer	0.000476	0.00358	CcSEcCtD
Ingenol Mebutate—Headache—Docetaxel—pancreatic cancer	0.000451	0.00339	CcSEcCtD
Ingenol Mebutate—Infection—Doxorubicin—pancreatic cancer	0.000446	0.00335	CcSEcCtD
Ingenol Mebutate—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00044	0.00331	CcSEcCtD
Ingenol Mebutate—Headache—Epirubicin—pancreatic cancer	0.000304	0.00228	CcSEcCtD
Ingenol Mebutate—Headache—Doxorubicin—pancreatic cancer	0.000281	0.00211	CcSEcCtD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	0.000153	0.00018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CD44—pancreatic cancer	0.000152	0.000179	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—EGFR—pancreatic cancer	0.000152	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCK—pancreatic cancer	0.000151	0.000178	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HSPA1A—pancreatic cancer	0.000151	0.000177	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EGFR—pancreatic cancer	0.000151	0.000177	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—PIK3CB—pancreatic cancer	0.000151	0.000177	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDH1—pancreatic cancer	0.00015	0.000176	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGF—pancreatic cancer	0.000149	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	0.000149	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IFNA2—pancreatic cancer	0.000149	0.000174	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CNR2—pancreatic cancer	0.000147	0.000173	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GLP1R—pancreatic cancer	0.000147	0.000173	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SMAD4—pancreatic cancer	0.000146	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—PIK3CA—pancreatic cancer	0.000145	0.000171	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCKAR—pancreatic cancer	0.000145	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—CXCL8—pancreatic cancer	0.000145	0.00017	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PIK3CD—pancreatic cancer	0.000144	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—KRAS—pancreatic cancer	0.000144	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—MYC—pancreatic cancer	0.000143	0.000168	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HES1—pancreatic cancer	0.000143	0.000168	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—KRAS—pancreatic cancer	0.000143	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PIK3CD—pancreatic cancer	0.000142	0.000166	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—pancreatic cancer	0.000141	0.000165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—JAG2—pancreatic cancer	0.000141	0.000165	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—AKT1—pancreatic cancer	0.00014	0.000164	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MEN1—pancreatic cancer	0.000139	0.000163	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN2A—pancreatic cancer	0.000137	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PIK3CB—pancreatic cancer	0.000137	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PIK3CB—pancreatic cancer	0.000137	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—HRAS—pancreatic cancer	0.000135	0.000158	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of mRNA—AKT1—pancreatic cancer	0.000133	0.000157	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PIK3CD—pancreatic cancer	0.000133	0.000156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	0.000132	0.000155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SHH—pancreatic cancer	0.000132	0.000155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—PIK3CA—pancreatic cancer	0.000132	0.000155	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—CXCL8—pancreatic cancer	0.000132	0.000155	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOTCH4—pancreatic cancer	0.000131	0.000154	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—PIK3CA—pancreatic cancer	0.000131	0.000154	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IAPP—pancreatic cancer	0.000131	0.000153	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CCND1—pancreatic cancer	0.000129	0.000152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—SMAD4—pancreatic cancer	0.000129	0.000152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CD44—pancreatic cancer	0.000127	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTHLH—pancreatic cancer	0.000125	0.000147	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TERT—pancreatic cancer	0.000125	0.000147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTCH1—pancreatic cancer	0.000125	0.000147	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PIK3CB—pancreatic cancer	0.000125	0.000147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—HRAS—pancreatic cancer	0.000124	0.000146	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PIK3CB—pancreatic cancer	0.000123	0.000145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GCG—pancreatic cancer	0.000122	0.000143	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—HRAS—pancreatic cancer	0.000122	0.000143	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—HRAS—pancreatic cancer	0.000121	0.000142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SMAD4—pancreatic cancer	0.00012	0.000141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HIF1A—pancreatic cancer	0.00012	0.000141	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TSC2—pancreatic cancer	0.00012	0.00014	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—AKT1—pancreatic cancer	0.000119	0.00014	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HES1—pancreatic cancer	0.000117	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—APOE—pancreatic cancer	0.000117	0.000137	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CCND1—pancreatic cancer	0.000116	0.000136	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PIK3CB—pancreatic cancer	0.000116	0.000136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—STK11—pancreatic cancer	0.000115	0.000135	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KDR—pancreatic cancer	0.000115	0.000135	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SST—pancreatic cancer	0.000115	0.000135	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTGS2—pancreatic cancer	0.000114	0.000134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of RNA—AKT1—pancreatic cancer	0.000114	0.000134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000113	0.000133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—JAG1—pancreatic cancer	0.000112	0.000132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOTCH3—pancreatic cancer	0.000112	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CTNNB1—pancreatic cancer	0.000111	0.00013	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SRC—pancreatic cancer	0.00011	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CTNNB1—pancreatic cancer	0.000109	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NFKBIA—pancreatic cancer	0.000109	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PTEN—pancreatic cancer	0.000108	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NOTCH1—pancreatic cancer	0.000108	0.000127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—AKT1—pancreatic cancer	0.000108	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—AKT1—pancreatic cancer	0.000107	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—VEGFA—pancreatic cancer	0.000107	0.000126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—BCL2L1—pancreatic cancer	0.000107	0.000125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PTEN—pancreatic cancer	0.000107	0.000125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—TSC2—pancreatic cancer	0.000106	0.000125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CNR1—pancreatic cancer	0.000106	0.000124	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—NRAS—pancreatic cancer	0.000106	0.000124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CG—pancreatic cancer	0.000106	0.000124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—NRAS—pancreatic cancer	0.000106	0.000124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGF—pancreatic cancer	0.000104	0.000123	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MYC—pancreatic cancer	0.000104	0.000122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TERT—pancreatic cancer	0.000103	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CG—pancreatic cancer	0.000103	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CTNNB1—pancreatic cancer	0.000102	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GCG—pancreatic cancer	0.000102	0.00012	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—SRC—pancreatic cancer	0.0001	0.000118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTEN—pancreatic cancer	9.98e-05	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CD—pancreatic cancer	9.94e-05	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—AKT1—pancreatic cancer	9.92e-05	0.000117	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—SRC—pancreatic cancer	9.89e-05	0.000116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—TYMS—pancreatic cancer	9.88e-05	0.000116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HIF1A—pancreatic cancer	9.83e-05	0.000115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TGFB1—pancreatic cancer	9.82e-05	0.000115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TSC2—pancreatic cancer	9.8e-05	0.000115	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AGTR1—pancreatic cancer	9.74e-05	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NFKBIA—pancreatic cancer	9.68e-05	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—STAT3—pancreatic cancer	9.67e-05	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—NRAS—pancreatic cancer	9.65e-05	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—pancreatic cancer	9.62e-05	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STK11—pancreatic cancer	9.6e-05	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—APOE—pancreatic cancer	9.59e-05	0.000113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NOTCH1—pancreatic cancer	9.54e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—NRAS—pancreatic cancer	9.51e-05	0.000112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MYC—pancreatic cancer	9.29e-05	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CD—pancreatic cancer	9.28e-05	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGF—pancreatic cancer	9.27e-05	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—SRC—pancreatic cancer	9.26e-05	0.000109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.19e-05	0.000108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—KRAS—pancreatic cancer	9.09e-05	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—KRAS—pancreatic cancer	9.09e-05	0.000107	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CD—pancreatic cancer	9.02e-05	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—PPARG—pancreatic cancer	9e-05	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MYC—pancreatic cancer	8.93e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—STAT3—pancreatic cancer	8.93e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—NRAS—pancreatic cancer	8.91e-05	0.000105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NOTCH1—pancreatic cancer	8.85e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—pancreatic cancer	8.79e-05	0.000103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—pancreatic cancer	8.67e-05	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.66e-05	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDH1—pancreatic cancer	8.63e-05	0.000101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGF—pancreatic cancer	8.56e-05	0.000101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SMAD4—pancreatic cancer	8.41e-05	9.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PIK3CA—pancreatic cancer	8.35e-05	9.81e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—PIK3CA—pancreatic cancer	8.35e-05	9.8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—CXCL8—pancreatic cancer	8.32e-05	9.77e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—KRAS—pancreatic cancer	8.3e-05	9.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MYC—pancreatic cancer	8.29e-05	9.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TGFB1—pancreatic cancer	8.27e-05	9.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PIK3CD—pancreatic cancer	8.24e-05	9.68e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HES1—pancreatic cancer	8.21e-05	9.64e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—KRAS—pancreatic cancer	8.19e-05	9.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—pancreatic cancer	8.11e-05	9.53e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CB—pancreatic cancer	8.09e-05	9.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—pancreatic cancer	8.08e-05	9.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—APOE—pancreatic cancer	8.03e-05	9.44e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CB—pancreatic cancer	7.86e-05	9.24e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CXCL8—pancreatic cancer	7.77e-05	9.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—HRAS—pancreatic cancer	7.73e-05	9.08e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—HRAS—pancreatic cancer	7.72e-05	9.07e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—KRAS—pancreatic cancer	7.66e-05	9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—PIK3CA—pancreatic cancer	7.63e-05	8.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—pancreatic cancer	7.63e-05	8.96e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PIK3CD—pancreatic cancer	7.61e-05	8.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—CXCL8—pancreatic cancer	7.56e-05	8.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—PIK3CA—pancreatic cancer	7.52e-05	8.83e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AKT1—pancreatic cancer	7.51e-05	8.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CASP3—pancreatic cancer	7.44e-05	8.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CG—pancreatic cancer	7.25e-05	8.52e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCND1—pancreatic cancer	7.24e-05	8.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TERT—pancreatic cancer	7.2e-05	8.45e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PIK3CB—pancreatic cancer	7.19e-05	8.44e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CTNNB1—pancreatic cancer	7.17e-05	8.42e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HRAS—pancreatic cancer	7.06e-05	8.29e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PIK3CA—pancreatic cancer	7.04e-05	8.27e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MMP9—pancreatic cancer	7.03e-05	8.26e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PPARG—pancreatic cancer	7e-05	8.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PTEN—pancreatic cancer	6.99e-05	8.21e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HRAS—pancreatic cancer	6.96e-05	8.17e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HIF1A—pancreatic cancer	6.88e-05	8.08e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TSC2—pancreatic cancer	6.87e-05	8.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—AKT1—pancreatic cancer	6.82e-05	8.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AKT1—pancreatic cancer	6.82e-05	8.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—APOE—pancreatic cancer	6.72e-05	7.89e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PIK3CB—pancreatic cancer	6.63e-05	7.79e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KDR—pancreatic cancer	6.58e-05	7.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—pancreatic cancer	6.57e-05	7.72e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HRAS—pancreatic cancer	6.51e-05	7.65e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SRC—pancreatic cancer	6.48e-05	7.61e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CD—pancreatic cancer	6.37e-05	7.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CTNNB1—pancreatic cancer	6.37e-05	7.48e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—VEGFA—pancreatic cancer	6.31e-05	7.41e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NFKBIA—pancreatic cancer	6.26e-05	7.35e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—STAT3—pancreatic cancer	6.25e-05	7.34e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—NRAS—pancreatic cancer	6.24e-05	7.32e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AKT1—pancreatic cancer	6.23e-05	7.32e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PTEN—pancreatic cancer	6.21e-05	7.29e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NOTCH1—pancreatic cancer	6.2e-05	7.28e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—AKT1—pancreatic cancer	6.2e-05	7.28e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—AKT1—pancreatic cancer	6.14e-05	7.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CG—pancreatic cancer	6.06e-05	7.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—NRAS—pancreatic cancer	6.06e-05	7.12e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGF—pancreatic cancer	5.99e-05	7.04e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CTNNB1—pancreatic cancer	5.88e-05	6.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MYC—pancreatic cancer	5.81e-05	6.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TGFB1—pancreatic cancer	5.79e-05	6.8e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—SRC—pancreatic cancer	5.76e-05	6.76e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—AKT1—pancreatic cancer	5.75e-05	6.76e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTEN—pancreatic cancer	5.73e-05	6.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—pancreatic cancer	5.68e-05	6.67e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CB—pancreatic cancer	5.56e-05	6.52e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—STAT3—pancreatic cancer	5.55e-05	6.52e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—NRAS—pancreatic cancer	5.54e-05	6.51e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—pancreatic cancer	5.52e-05	6.49e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—pancreatic cancer	5.51e-05	6.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KRAS—pancreatic cancer	5.37e-05	6.3e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CD—pancreatic cancer	5.33e-05	6.26e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—SRC—pancreatic cancer	5.32e-05	6.24e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—PIK3CA—pancreatic cancer	5.28e-05	6.2e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—KRAS—pancreatic cancer	5.22e-05	6.13e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MYC—pancreatic cancer	5.13e-05	6.03e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—STAT3—pancreatic cancer	5.13e-05	6.02e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—NRAS—pancreatic cancer	5.11e-05	6.01e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—pancreatic cancer	5.05e-05	5.93e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—PIK3CA—pancreatic cancer	4.93e-05	5.79e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTEN—pancreatic cancer	4.8e-05	5.64e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—PIK3CA—pancreatic cancer	4.79e-05	5.63e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—pancreatic cancer	4.77e-05	5.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KRAS—pancreatic cancer	4.77e-05	5.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MYC—pancreatic cancer	4.76e-05	5.59e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TGFB1—pancreatic cancer	4.75e-05	5.58e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—pancreatic cancer	4.66e-05	5.47e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CB—pancreatic cancer	4.65e-05	5.46e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HRAS—pancreatic cancer	4.56e-05	5.36e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CXCL8—pancreatic cancer	4.46e-05	5.24e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—HRAS—pancreatic cancer	4.44e-05	5.21e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—KRAS—pancreatic cancer	4.4e-05	5.17e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—PIK3CA—pancreatic cancer	4.38e-05	5.14e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AKT1—pancreatic cancer	4.31e-05	5.06e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CASP3—pancreatic cancer	4.27e-05	5.02e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCND1—pancreatic cancer	4.16e-05	4.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CTNNB1—pancreatic cancer	4.12e-05	4.84e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HRAS—pancreatic cancer	4.05e-05	4.76e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PIK3CA—pancreatic cancer	4.04e-05	4.75e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MMP9—pancreatic cancer	4.04e-05	4.74e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKT1—pancreatic cancer	4.03e-05	4.73e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PTEN—pancreatic cancer	4.01e-05	4.71e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AKT1—pancreatic cancer	3.92e-05	4.6e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HRAS—pancreatic cancer	3.74e-05	4.39e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SRC—pancreatic cancer	3.72e-05	4.37e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—VEGFA—pancreatic cancer	3.63e-05	4.26e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—STAT3—pancreatic cancer	3.59e-05	4.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—NRAS—pancreatic cancer	3.58e-05	4.21e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AKT1—pancreatic cancer	3.58e-05	4.2e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—AKT1—pancreatic cancer	3.56e-05	4.18e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PIK3CA—pancreatic cancer	3.39e-05	3.98e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MYC—pancreatic cancer	3.34e-05	3.92e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFB1—pancreatic cancer	3.33e-05	3.91e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKT1—pancreatic cancer	3.3e-05	3.88e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—pancreatic cancer	3.26e-05	3.83e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KRAS—pancreatic cancer	3.08e-05	3.62e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—PIK3CA—pancreatic cancer	2.83e-05	3.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AKT1—pancreatic cancer	2.77e-05	3.25e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—pancreatic cancer	2.74e-05	3.22e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HRAS—pancreatic cancer	2.62e-05	3.08e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKT1—pancreatic cancer	2.31e-05	2.72e-05	CbGpPWpGaD
